Neurocrine Biosciences (NBIX) Competitor Comparison
We are evaluating the key criteria listed to compare Neurocrine Biosciences (NBIX) against its competitors in the Biotechnology industry.
Market Capitalization
11 / 368Gross Profits
12 / 278Total Revenue
11 / 300EBITDA
8 / 337Free Cashflow
6 / 352Quick Ratio
282 / 357Earnings per Share
6 / 359Dividend yield
0 / 6Total Cash
21 / 358Performance 3 years
82 / 368Performance 5 years
115 / 368Performance 10 years
18 / 368Linearity 3 years
43 / 368Linearity 5 years
35 / 367Linearity 10 years
338 / 368Total Rank
207 / 368Dividend Rank
215 / 368Valuation Rank
134 / 368Piotroski Rank
13 / 368Muliplier Rank
163 / 368Free Cashflow - NBIX ranking 6 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.